These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1364186)

  • 1. Progression of HIV-infection: markers or determinants.
    Phair JP; Farzadegan H; Chmiel J; Muñoz A; Detels R; Saah A; Kaslow R
    Trans Am Clin Climatol Assoc; 1993; 104():123-8; discussion 128-9. PubMed ID: 1364186
    [No Abstract]   [Full Text] [Related]  

  • 2. [The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons].
    Günthard H; Opravil M; Ledergerber B; Olsson K; Vogt M; Fierz W; Lüthy R
    Dtsch Med Wochenschr; 1993 May; 118(20):737-45. PubMed ID: 8099005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.
    Hofmann B; Wang YX; Cumberland WG; Detels R; Bozorgmehri M; Fahey JL
    AIDS; 1990 Mar; 4(3):207-14. PubMed ID: 1972020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexplained CD4 + T-lymphocyte depletion in persons without evident HIV infection--United States.
    Infect Control Hosp Epidemiol; 1992 Oct; 13(10):618-21. PubMed ID: 1361504
    [No Abstract]   [Full Text] [Related]  

  • 6. CD4/CD8 counts and immunoglobulin levels in anti-HIV-1-positive people with and without lymphadenopathy.
    Mikulecký M; Mayer V; Sobota K
    AIDS; 1990 Feb; 4(2):168-9. PubMed ID: 1970257
    [No Abstract]   [Full Text] [Related]  

  • 7. CD4+ T-lymphocytopenia without HIV infection.
    Heymann DL; Belsey E; Esparza JG
    N Engl J Med; 1993 Jun; 328(25):1848; author reply 1849-50. PubMed ID: 8099197
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current distribution of CD4+ T-lymphocyte counts among adults in the United States with human immunodeficiency virus infections: estimates based on the experience of the U.S. Army. U.S. Army Retrovirus Research Group.
    Brundage JF; McNeil JG; Miller RN; Gardner LI; Harrison SM; Hawkes C; Craig DB; Redfield R; Burke DS
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):92-4. PubMed ID: 1967147
    [No Abstract]   [Full Text] [Related]  

  • 10. From the Centers for Disease Control. Unexplained CD4+ T-lymphocyte depletion, persons without evident HIV infection.
    JAMA; 1992 Sep; 268(10):1254-5. PubMed ID: 1354756
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Centers for Disease Control. Update: CD4+ T-lymphocytopenia in persons without evident HIV infection--United States.
    JAMA; 1992 Sep; 268(10):1252. PubMed ID: 1354755
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.
    Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M
    Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of prognostic markers in HIV infection: implications for pathogenesis.
    Phillips AN
    AIDS; 1992 Nov; 6(11):1391-4. PubMed ID: 1361749
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.
    Rachinger A; Kootstra NA; Gijsbers EF; van den Kerkhof TL; Schuitemaker H; van 't Wout AB
    AIDS; 2012 Jul; 26(12):1517-22. PubMed ID: 22555160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
    Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
    PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals.
    Taylor JM; Tan SJ; Detels R; Giorgi JV
    AIDS; 1991 Feb; 5(2):159-67. PubMed ID: 1674418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic CD4+ T-lymphocytopenia.
    DeHovitz JA; Feldman J; Landesman S
    N Engl J Med; 1993 Sep; 329(14):1045-6. PubMed ID: 8103568
    [No Abstract]   [Full Text] [Related]  

  • 18. CD4+ T-lymphocytopenia without HIV infection.
    Sheppard H; Winkelstein W; Lang W; Charlebois E
    N Engl J Med; 1993 Jun; 328(25):1847-8. PubMed ID: 8099196
    [No Abstract]   [Full Text] [Related]  

  • 19. After Concorde.
    Gazzard BG
    BMJ; 1993 Apr; 306(6884):1016-7. PubMed ID: 8098237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunodeficiency and opportunistic processes in the absence of human immunodeficiency virus infection].
    Soriano V; Castro A
    Med Clin (Barc); 1993 Mar; 100(9):351-5. PubMed ID: 8095996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.